Invention Grant
- Patent Title: Multi-functional and multi-valent interleukin-TGF-beta receptor fusion polypeptides
-
Application No.: US17574479Application Date: 2022-01-12
-
Publication No.: US11407814B2Publication Date: 2022-08-09
- Inventor: Claudia Ania Penafuerte Diaz
- Applicant: CURA THERAPEUTICS, INC.
- Applicant Address: CA Montreal
- Assignee: CURA THERAPEUTICS, INC.
- Current Assignee: CURA THERAPEUTICS, INC.
- Current Assignee Address: CA Montreal
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07K14/71
- IPC: C07K14/71 ; C07K14/55 ; C07K14/54 ; C07K19/00 ; A61P35/00 ; A61K38/00
Abstract:
Provided are multi-functional and multi-valent fusion polypeptides comprising an interleukin polypeptide and two or more TGFβ ligand-binding polypeptides. The compositions and methods provided herein are useful in the application of preventing tumorigenesis and treating cancer.
Public/Granted literature
- US20220127332A1 MULTI-FUNCTIONAL AND MULTI-VALENT INTERLEUKIN-TGF-BETA RECEPTOR FUSION POLYPEPTIDES Public/Granted day:2022-04-28
Information query
